Conference Chairman's Lecture
May 20 (Sat) 9:20AM〜
Masanari Itokawa
Deputy Director, Tokyo Metropolitan Institute of Medical Science
Born June 21, 1961 Tokyo Male 60 years old
Biography:
1989 Graduated from Saitama Medical University
Department of Neuropsychiatry, Tokyo Medical and Dental University
Resident (Professor Yudoo)
1990 Psychiatry Department, Yotsukura Hospital, Fukushima Prefecture Full-time doctor
1991 Department of Human Genetics, University of Tsukuba
_cc781905-5cde-3194 -bb3b-136bad5cf58d_ Research Student (Associate Professor Tadao Ariwa)
1993 Department of Neuropsychiatry, Tokyo Medical and Dental University
_cc781905-5cde-3194 -bb3b-136bad5cf58d_ Doctor (Professor Yudoo)
1994 Department of Biochemistry, Brain Research Institute, University of Tokyo
_cc781905-5cde-3194 -bb3b-136bad5cf58d_ Research Student (Professor Tatsuya Haga)
1996 Molecular Neurobiology Branch,
_cc781905-5cde-3194 -bb3b-136bad5cf58d_ National Institute on Drug Abuse,
_cc781905-5cde-3194 -bb3b-136bad5cf58d_ National Institutes of Health,
_cc781905-5cde-3194 -bb3b-136bad5cf58d_ Visiting Fellow (Professor George Uhl)
1999 RIKEN Molecular Psychiatry Research Team
_cc781905-5cde-3194 -bb3b-136bad5cf58d_ Researcher(Takeo Yoshikawa Team Leader)
2001 Division of Schizophrenia, Tokyo Metropolitan Institute of Psychiatry
_cc781905-5cde-3194 -bb3b-136bad5cf58d_ Department Head (Deputy Counselor)
Part-time doctor, Department of Psychiatry, Matsuzawa Metropolitan Hospital
2004 Tokyo Metropolitan Institute of Psychiatry
_cc781905-5cde-3194 -bb3b-136bad5cf58d_ Schizophrenia Project
_cc781905-5cde-3194 -bb3b-136bad5cf58d_ Project Leader.(Deputy Counselor)
2011 Tokyo Metropolitan Institute of Medical Science (Integrated transfer of research institutes)
Schizophrenia/Depression Project
_cc781905-5cde-3194 -bb3b-136bad5cf58d_ Project leader (counselor)
_cc781905-5cde-3194 -bb3b-136bad5cf58d_ Chief
2015 President of the 10th Annual Meeting of the Japanese Society for Schizophrenia
Tokyo Metropolitan Institute of Medical Science
_cc781905-5cde-3194 -bb3b-136bad5cf58d_ Director of Hospital Collaborative Research Center
2018 Tokyo Metropolitan Institute of Medical Science
_cc781905-5cde-3194 -bb3b-136bad5cf58d_ Deputy Director
2020 Tokyo Metropolitan Institute of Medical Science
_cc781905-5cde-3194 -bb3b-136bad5cf58d_ New Corona Countermeasures Special Team General Manager
Specialties: Psychiatry, molecular biology, philosophy of science, currently interested in Edo period economic policies, Zen Buddhism, and folklore.
Hobbies: Taking and appreciating photos, Iai, skiing, swimming, playing catch at the office during lunch break, reading, listening to music
Awards:
1989 Chairman Moroyama Award (Saitama Medical University)
1992 Shimazaki-Shimazono-Takahashi Academic Award (Tokyo Medical and Dental University)
2008 Tokyo Governor Award (Invention Discovery)
2011 Schizophrenia Study Group Grand Prize
2016 Healthy Society Award (Japanese Nursing Association)
director:
Director of the Japanese Society for Schizophrenia, President of the 10th Annual Meeting of the Japanese Society for Schizophrenia
Director of Japanese Society of Psychoneuropharmacology
Councilor, Japanese Society of Biological Psychiatry
Visiting Professor, Graduate School of Frontier Sciences, The University of Tokyo
Saitama Medical University part-time lecturer
book:
“Why Clinicians Do Research” (Seiwa Shoten), 2013
"Until schizophrenia opens the secret door" (Seiwa Shoten) 2014
"When Scientists Connect Brain and Heart" (Community Mental Health and Welfare Organization) 2015
"Schizophrenia as a Syndrome: A Reexamination from Biological Research" Series Philosophy of Psychiatry, Vol. 1, Chapter 6 (University of Tokyo Press), 2016
"Archaeology of the Brain and Mind" (Nippon Hyoronsha) 2020
Co-authored “Study of Weakness: Understanding the Corona Era with Weakness” (Kumpuru), 2020
main literature
1. Masanari Itokawa Brain and Mind: Does Molecular Biology Elucidate Mental Illness? Scientific Philosophy 47-2, 2015
2. Masanari Itokawa Science and Superstition, Schizophrenia no Hiroba No.5 Page161-174,2015
3. Masanari Itokawa, Makoto Arai, Mitsuhiro Miyashita and others Challenges and Perspectives in Genetic Research of Schizophrenia Heterogeneity and Complex Systems Psychiatry (0488- 1281) Vol.55 No.12 Page1133-1143,2013
4. Masanari Itokawa, Makoto Arai, Chie Ichikawa et al. 2658) Vol.113 No.7 Page672-678,2011
5. Miyashita M, Arai M, Kobori A, et al. Clinical features of schizophrenia with en-hanced carbonyl stress.Schizophr Bull.;40(5) :1040-1046, 2014
6. Arai M, Yuzawa H, Nohara I, et al. Enhanced carbonyl stress in a subpopulation of schizophrenia.
Arch Gen Psychiatry. ;67(6):589-597, 2010
7. Sora I, Hall FS, Andrews AM, et al. Molecular mechanisms of cocaine reward: com-bined dopamine and serotonin transporter knockouts eliminate cocaine place prefer- ence.
Proc Natl Acad Sci US A. 24;98(9):5300-5305, 2001
8. Lin Z, Itokawa M, Uhl GR. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression.FASEB J.;14(5 ): 715-728, 2000
9. Itokawa M, Toru M, Ito K, et al Sequestration of the short and long isoforms of do-pamine D2 receptors expressed in Chinese hamster ovary cells. Mol Pharma-col. ;49(3):560-566, 1996
10. Arinami T, Itokawa M, Enguchi H, et al. Association of dopamine D2 receptor molecu-lar variant with schizophrenia.Lancet. 19;343(8899 ): 703-704.1994